BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2025 10:04:51 AM | Browse: 41 | Download: 140
 |
Received |
|
2025-05-19 09:14 |
|
Peer-Review Started |
|
2025-05-19 09:14 |
|
First Decision by Editorial Office Director |
|
2025-06-10 08:34 |
|
Return for Revision |
|
2025-06-10 08:34 |
|
Revised |
|
2025-06-18 03:01 |
|
Publication Fee Transferred |
|
2025-06-19 13:33 |
|
Second Decision by Editor |
|
2025-07-16 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-16 06:48 |
|
Articles in Press |
|
2025-07-16 06:48 |
|
Edit the Manuscript by Language Editor |
|
2025-07-21 10:18 |
|
Typeset the Manuscript |
|
2025-08-08 01:55 |
|
Publish the Manuscript Online |
|
2025-08-18 10:04 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Efficacy of N-acetylcysteine vs dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Preeyamas Koonsiripaiboon, Witchakorn Ruamtawee, Nitipon Simasingha, Wasu Tanasoontrarat, Torpong Claimon and Supatsri Sethasine |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Faculty of Medicine Vajira Hospital, Navamindradhiraj University Research Fund |
1-67 |
|
| Corresponding Author |
Supatsri Sethasine, Associate Professor, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Dusit 10300, Bangkok, Thailand. supatsri@nmu.ac.th |
| Key Words |
Dexamethasone; Hepatocellular carcinoma; N-acetylcysteine; Postembolization syndrome; Transarterial chemoembolization |
| Core Tip |
N-acetylcysteine significantly reduces the incidence of postembolization syndrome compared with dexamethasone in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial chemoembolization; however, both treatments have comparable effects on liver function recovery. |
| Publish Date |
2025-08-18 10:04 |
| Citation |
Koonsiripaiboon P, Ruamtawee W, Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of N-acetylcysteine vs dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial. World J Gastroenterol 2025; 31(31): 109630 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i31/109630.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i31.109630 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
